(redirected from drug-resistant hypertension)
Also found in: Dictionary, Medical, Encyclopedia.
  • noun

Synonyms for hypertension

a common disorder in which blood pressure remains abnormally high (a reading of 140/90 mm Hg or greater)

References in periodicals archive ?
Based in Bellevue, Washington, and Menlo Park, California, Kona Medical is committed to alleviating the suffering and health risks associated with drug-resistant hypertension with a more effective, less invasive approach to renal artery denervation.
The study enrolled 50 patients across 5 centers in Australia and Europe, using the Symplicity([R]) Catheter System([TM])to treat patients with drug-resistant hypertension.
We are pleased with the early clinical results to date and are optimistic that this novel treatment approach could offer a new option for patients with drug-resistant hypertension," said Professor Peter de Leeuw, professor of medicine/ hypertension at the University of Maastricht in The Netherlands.
These favorable results are promising for the many people with drug-resistant hypertension," said Nadim Yared, president and CEO of CVRx.
MINNEAPOLIS & CHICAGO -- Early findings from the Rheos[TM] Trial show a significant reduction in blood pressure in patients with drug-resistant hypertension who have a systolic blood pressure of 160 mmHg or greater.
The new HTN sector on cvPipeline covers a rapidly emerging landscape of drug-resistant hypertension products and clinical trials, including:
These advancements deliver on our strategy to bring new innovations to a developing market to provide options for patients who currently do not have an adequate treatment for their uncontrolled drug-resistant hypertension.
Renal denervation has the promise of successfully treating currently uncontrolled, drug-resistant hypertension, a major health problem.
Kona's proprietary technology, which utilizes externally delivered ultrasound energy to ablate the renal nerves, can enable non-invasive treatment for drug-resistant hypertension and has significant potential advantages over alternative methods.
23 /PRNewswire/ -- Preclinical data of a novel therapy designed to treat drug-resistant hypertension (high blood pressure) was presented Tuesday, September 21st, at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 Conference in Washington, DC, by Christopher D.